No | Parameter | Average value/value | Range | Source |
---|---|---|---|---|
1 | Vaccine delivery cost per FIG | $ 10.4 | $ 9.5-$ 11.3 | Costing study |
2 | Cancer treatment cost | Costing study | ||
Scenario 5 (IA1 - IIB proximal treated by Radical hysterectomy) | $ 368.3 | N/A | ||
Scenario 6 (IA1 - IIB proximal treated by Radical hysterectomy + Chemoradiation) | $ 8700.1 | N/A | ||
Scenario 7 (IA1 - IIB proximal treated by Radical hysterectomy + Radio therapy (Intr)) | $ 2209.6 | N/A | ||
Scenario 8 (IA1 - IIB proximal treated by Radical hysterectomy + Radio-therapy (External beam)) | $ 1449.9 | N/A | ||
Scenario 9 (IIB distant – IVB treated by Chemoradiation) | $ 11448.1 | N/A | ||
Scenario 10 (IIB distant – IVB treated by Radio therapy (Intra + External)) | $ 5166.52 | N/A | ||
Scenario 11 (average cost of all scenarios) | $ 4,890.44 | N/A | ||
3 | DALYs lost per non-fatal cancer episode | 0.7 | Literature review | |
4 | DALYs lost per fatal cancer episode (excluding life years lost) | 0.8 | Literature review | |
5 | Epidemiological data | Literature review | ||
Cervical cancer incidence in 2012 | 6.1 per 100000 | GLOBOCAN 2012 | ||
20.5 per 100000 | ||||
26.7 per 100000 | ||||
31.3 per 100000 | ||||
32.1 per 100000 | ||||
26.2 per 100000 | ||||
20.5 per 100000 | ||||
13 per 100000 | ||||
Cervical cancer mortality in 2012 | 1.1 per 100000 | GLOBOCAN 2012 | ||
6.5 per 100000 | ||||
15.1 per 100000 | ||||
18.8 per 100000 | ||||
21.3 per 100000 | ||||
21.8 per 100000 | ||||
20 per 100000 | ||||
16.1 per 100000 | ||||
5.3 per 100000 | ||||
All-cause mortality in 2012 | 100 - 52 800 per 100 000 (depending on age) | National statistics |